Invited Speaker

Tsung-Hsien Lee
Director, Institute of Medicine, Chung-Shan Medical University
Professor, Institute of
Medicine and Department of Obstetrics and Gynecology, Chung-Shan
Medical University
Bio: I graduated from Taipei Medical
College (now Taipei Medical University) with a degree of medical
doctor in 1995. In July 1997, I entered the National Taiwan
University Hospital, Taipei, Taiwan as a resident physician in the
Department of Obstetrics and Gynecology, and after four years of
residency training, I was admitted to Taiwan Association of
Obstetrics and Gynecology as a specialist in 2001. In the same year,
I entered the Division of Reproductive Endocrinology and
Infertility, Department of Obstetrics and Gynecology, National
Taiwan University Hospital as a trainee physician, receiving two
years of subspecialty training in infertility, and during the period
of chief resident and two years of training physician, I studied at
the Institute of Clinical Medicine, National Taiwan University
College of Medicine, and obtained a master's degree in medicine in
2003 The master's thesis focused on the new IVF treatment at that
time, and discussed the related phenomena and applications of the
gonadotropin antagonist protocol for IVF patients.
In July 2003, I served as an attending physician in the Department
of Obstetrics and Gynecology of National Taiwan University Hospital
and entered the doctoral program of the Institute of Clinical
Medicine, National Taiwan University College of Medicine, where I
focused on the correlation with reactive nitrogen species (such as
nitric oxide) and antioxidants (such as glutathione) during
embryonic development during IVF treatment. In 2005, I was qualified
as a lecturer by the Ministry of Education and taught trainee
physician in the Department of Obstetrics and Gynecology of the
College of Medicine of National Taiwan University.
From April 2007 to the Chung Shan Medical University Hospital, he
served as an attending physician in the Department of Obstetrics and
Gynecology, and in August 2008, he was qualified as an assistant
professor by the Ministry of Education, and at the same time worked
at the National Taiwan University College of Medicine. In August
2009, I transferred to the Institute of Medicine, Chung Shan Medical
University as a full-time assistant professor, and since then, in
addition to medical students, I has also been required to teach
master's students and help graduate students learn clinical research
methods. After receiving his Ph.D. in Clinical Medicine from
National Taiwan University College of Medicine in 2012, he taught
more students from the Institute of Medicine of Chung Shan Medical
University to doctoral students. During this period, my research
areas included not only the effects of oxidative stress on sperm and
embryos in reproductive medicine, but also in the field of stem
cells. In February 2021, he obtained the qualification of professor
appointed by the Ministry of Education, and the number of medical
students, master's students, and doctoral students under my guidance
gradually increased, and my research fields also expanded from
obstetrics and gynecology and reproductive medicine to medical
research such as cancer, urology, and big data. I have published
more than 100 SCI papers so far.
Since 2010, I have served as the director of the Center of
Reproductive Medicine in the Department of Obstetrics and Gynecology
of Chung Shan Medical University Hospital, presided over the
Reproductive Medicine Laboratory, and is responsible for managing
the relevant personnel of the Center of Reproductive Medicine and
the affairs related to IVF treatment. Since 2015, I have been
elected as a supervisor of the Taiwan Society for Reproductive
Medicine for five consecutive terms, and at the same time also
served as a supervisor and director of the Taiwan Association of
Obstetrics and Gynecology, and engaged in the public affairs of
reproductive medicine.
Speech Title: From Pixels to Pregnancies: The Application of AI for Reproductive Medicine
Speech Abstract: Artificial intelligence
(AI) now performs specialist-level tasks in several fields of
medicine, and reproductive medicine is a natural candidate. In vitro
fertilization (IVF) combines repetitive decisions, marked
inter-observer variability, abundant digital data and measurable
outcomes. This talk introduces AI for obstetricians and
gynecologists through a five-rung evidence ladder, from
retrospective model development to randomized trials and real-world
implementation. The aim is to help clinicians see where AI fits in
the IVF workflow and how to appraise it critically. Four
applications are reviewed. First, deep learning models for embryo
selection showed high accuracy in retrospective studies, yet the
first large randomized trial (1,066 patients, 14 clinics) did not
demonstrate noninferiority to embryologists for clinical pregnancy
(46.5% vs. 48.2%), although the AI selected the same embryo in most
cases and worked faster. Second, non-invasive ploidy prediction
reached an AUC of 0.76 internally but lower values at external
clinics. Third, models for gonadotrophin dosing, trigger timing and
sperm retrieval remain largely retrospective. Fourth, large language
models give useful fertility counseling information but produce
occasional factual errors. The talk closes with five questions
clinicians should ask before adopting any AI tool, concerning
training data, outcome, level of evidence, transparency and
reporting standards.


